A comparator study using a target trial emulation framework compared the risk for fall-related visits and hospitalizations in the 6 months after initiating gabapentin versus duloxetine among patients with evidence of common conditions for which either medication could be reasonable to use, such as neuropathy or fibromyalgia.
